| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Postfusion glycoprotein F0/post-F protein (RSV) | HOT RSF-V52H9 | HRSV (B) Post-fusion glycoprotein F0, His Tag (MALS verified) | Human respiratory syncytial virus B (strain B1) | HEK293 | MALSSDS-PAGE | $465.00 50ug |   | ||
| Postfusion glycoprotein F0/post-F protein (RSV) | HOT RSF-V52H6 | HRSV (A) Post-fusion glycoprotein F0, His Tag (MALS verified) | Human respiratory syncytial virus A (strain A2) | HEK293 | MALSSDS-PAGE | $465.00 50ug | |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| RGN-259 | Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 | Phase 3 Clinical | National Institutes Of Health | Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica | Details |
| Fasinumab | SAR-164877; MT-5547; R-475; REGN-475 | Phase 3 Clinical | Abdominal Pain; Sciatica; Osteoarthritis, Knee; Back Pain; Osteoarthritis; Low Back Pain; Osteoarthritis, Hip | Details | |
| MEDI-7352 | MEDI-7352 | Phase 2 Clinical | Medimmune | Chronic Pain; Diabetic Neuropathies; Osteoarthritis, Knee | Details |
| N-Hexacosanol | tCFA15; TAC-302 | Phase 2 Clinical | Meiji Seika Pharma Co Ltd | Urinary Bladder, Underactive; Urinary Bladder, Overactive | Details |
| Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical) | Phase 2 Clinical | Shenyang Sunshine Pharmaceutical Co Ltd | Bone metastases; Cancer Pain | Details | |
| EP-9001A | EP-9001A | Phase 2 Clinical | Chengdu Youluo Biotechnology Co Ltd | Bone metastases; Cancer Pain; Pain | Details |
| DS-002 | DS-002 | Phase 2 Clinical | Dartsbio Pharmaceuticals Ltd | Pain; Cancer Pain | Details |
| Atinumab | NG-101; ATI-355 | Phase 2 Clinical | Novartis Pharma Ag | Spinal Cord Injuries; Gastroparesis; Diabetic Gastroparesis | Details |
| SSS-40 | SSS-40; SSS-40-anti-NGF Ab; SSS40 anti-NGF Ab | Phase 1 Clinical | 3sbio Inc | Cancer Pain; Bone Neoplasms; Osteoarthritis | Details |
| Luvagrobart | AK-115 | Phase 1 Clinical | Zhongshan Akeso Biopharma Co Ltd | Pain; Cancer Pain | Details |
| TNM-009 | TNM-009; TNM009 | Phase 1 Clinical | Zhuhai Trinomab Pharmaceutical Co Ltd | Cancer Pain; Pain | Details |
| SMR-7694 | SMR-7694; SMR7694 | Phase 1 Clinical | Sinobioway Biomedicine Co Ltd | Osteoarthritis | Details |
| Neuroregenerative agents (iNtRON Biotechnology) | Clinical | Intron Biotechnology | Nervous System Diseases | Details |
